Akrivis Technologies
Akrivis’ technology platform delivers ultrasensitive diagnostics and theranostics with high-resolution imaging and targeted therapies
- Stage Prototype Ready
- Industry Biotechnology
- Location Cambridge, MA, USA
- Currency EUR
- Founded March 2009
- Employees 4
- Website akrivis.com
Company Summary
Akrivis is a privately held biotech company founded in 2009 in Cambridge, Massachusetts. Its patented ADAPT™ technology platform delivers a theranostic combination of ultrasensitive in vitro diagnostics, high-resolution imaging and targeted therapeutics. Akrivis, via a French entity, and the CEA-LETI in Grenoble are in final discussions to form a shared R&D laboratory in order to combine their respective ADAPT™ and Lipidot® technologies
Team
-
Christopher SCANNELLChief Business Officer
-
Joel BERNIACPresident & CEO
-
Ban-An KHAWChief Scientific Officer
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.